Payer Briefs: Express Scripts Pricing Pilot; HHS Risk Adjustment; Value Frameworks
This article was originally published in The Pink Sheet Daily
Executive Summary
Indication-based pricing experiment by Express Scripts gets off to a quiet start; HHS makes progress on factoring Rx spending in its risk adjustment calculations for ACA plans and the National Pharmaceutical Council releases recommended standards for drug value assessments.